Study links autism symptoms to disregulated levels of neurotransmitter GABA; flags potential avenue for developing treatments
December 17, 2015
Imbalances in inhibitory GABA brain cell receptor activity (left) have been implicated in autism. A new study looks more closely at GABA brain activity and autism-related difficulties with screening out distracting images. The findings suggests a promising direction for future medicines. Illustration courtesy SAGE Therapeutics.
For the first time, researchers have documented a direct link between the severity of someone’s autism symptoms and brain levels of the neurotransmitter GABA, or gamma-aminobutyric acid. The findings advance hope for treatments that ease autism symptoms by enhancing the action of GABA – the brain’s primary “calming,” or inhibitory, neurotransmitter.

















